Obesity, Microbiome, & Cancer: Mechanistic Considerations

September 9, 2021
12:00 – 2:00 PM ET

Emerging evidence suggests that many dietary effects on human health and disease are mediated by actions of the GI microbiome. Clinical and preclinical evidence indicates the GI microbiome can regulate host inflammatory responses, metabolism, energy intake balance, and obesity outcomes, although the molecular mechanisms that control these pathways are poorly understood. The webinar will feature leading investigators whose work explores some of the pathways, models, and bacteria that are involved in influencing obesity and cancer outcomes.

This webinar is part of the NCI Obesity & Cancer Webinar Series, which aims to foster cross-disciplinary research on obesity that can help prevent, treat, and/or control cancer.


Christian Jobin, Ph.D.
University of Florida College of Medicine


Liza Makowski Ph.D.
University of Tennessee Health Science Center


Matam Vijay-Kumar, Ph.D.
The University of Toledo-Microbiome Consortium



Stephen D. Hursting, Ph.D.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill



Phil Daschner, Ph.D.
National Cancer Institute


Sharon Ross, Ph.D., M.P.H.
National Cancer Institute


Reasonable Accommodations

Individuals who need reasonable accommodations to participate in this event should contact ncidccpsbrpadvances@mail.nih.gov. Requests should be made at least five business days in advance of the event.

Last Updated
June 24, 2021